u/ingrid_correia

Published reimbursement criteria exist in most member states and are usually available in the national language. They are the authoritative answer to eligibility questions that this board can only guess at.

a mechanism you can state is not a mechanism you have demonstrated

Does injection-site soreness follow the day after the shot, or is it spread across the week?

Push back: "gentler than sema" is a population statement. Plenty of people on this board have the opposite experience and they are not doing it wrong.

Research-use-only material is not approved for human use. Anything in this thread about how a research vial "should" titrate is a discussion about chemistry, not a plan.

the appetite effect is blunter than sema, in a good way, most weeks

It is a dual GIP and GLP-1 receptor agonist, and the GIP arm is the part that has no equivalent in the semaglutide threads.

Agreed, with one qualifier: that is the mean of the top arm and the spread around it was enormous.

postprandial excursions are where most of the improvement shows up first

Pen or vial?

Agreed, with one qualifier: that is the mean of the top arm and the spread around it was enormous.

Agree. The GIP component is the interesting half and it barely gets discussed outside c/glp1science.

This. The published reimbursement criteria are the document to read, and most member states do publish them.

postprandial excursions are where most of the improvement shows up first

Storage conditions came back specific rather than generic when I asked.

bastian_aalto is right that a purity figure without a method is not comparable to one with a method.

GIP receptor biology is genuinely unsettled — there is a live argument about agonism versus antagonism at the receptor — and the clinical results are robust regardless, which is an uncomfortable and interesting position.

What pack size is that price for?

2.5mg is a four-week starting dose, not a maintenance dose. Worth being precise since people search these threads.

the less-tested the compound, the more the identity test matters

This is the rule for anything unusual. Identity before anything else.

Came off sema and onto tirz with a two-week gap. The first month was flat and I assumed I had made a mistake. Month two it moved.

Vials and pens carry the same molecule; what differs is fill volume, device tolerance and whether you are doing your own arithmetic. Neither is inherently more accurate.

Cosigning on GIP. The genuinely interesting thing is that the biology is not settled and the clinical result is nonetheless robust.

zepbound and mounjaro are the same compound with different labels

That percentage is body weight change, not body fat. Different measurement, and the distinction gets lost every time.

2.5mg is a four-week starting dose, not a maintenance dose. Worth being precise since people search these threads.

Pen or vial? The step sizes available differ and it changes this answer.

the diabetes trials report different endpoints from the obesity ones

Supply notices are issued nationally. A notice in one member state does not imply availability problems in another, even for the same product.

What does time in range look like, not just the average?

Are you quoting a diabetes trial or an obesity one?

read the discussion section, that is where the honesty lives

12kg over 46 weeks, never went past 10mg, and reflux stayed mild the whole way.

This. The step interval is a floor, and reading it as a timetable is the most expensive mistake in the thread.

Which week did the appetite change actually land for you?

Not convinced — cross-border prescription recognition is narrower than you are describing and the exceptions matter.

Tolerance to the gastric effect develops with continued exposure while the appetite effect largely persists. That single fact explains most of the "it settles but it still works" pattern the side-effect board reports.

I would separate the two claims. That the GIP arm exists is uncontroversial; that it explains your sulphur burps pattern is a guess.

The 21% figure is a 72-week mean on the highest arm.

swirl_dont_shake is right that the two molecules are not interchangeable. There is no published conversion and the ones circulating are invented.

Research-use-only material is not approved for human use. Anything in this thread about how a research vial "should" titrate is a discussion about chemistry, not a plan.

Which week did the appetite change actually land for you?

the peripheral and central stories are not in competition